(1)
Association of Ruxolitinib Cream Initiation With Continued Reduction in Use of Other Topical Treatments, Oral Corticosteroids, and Biologics for Atopic Dermatitis. J of Skin 2024, 8 (6), s455. https://doi.org/10.25251/skin.8.supp.455.